NDC 68382-255 – Oxybutynin

Oxybutynin Chloride 5 mg/1 · Tablet, Film Coated, Extended Release · Oral

Human Prescription Drug 4 recalls

Product NDC68382-255

Product details

Brand name
Oxybutynin
Generic name
Oxybutynin
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
Tablet, Film Coated, Extended Release
Route
Oral
Marketing category
ANDA · ANDA202332
Marketed since
August 10, 2017
Listing expires
December 31, 2026
Pharmacologic class
Cholinergic Muscarinic Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Oxybutynin →

Package NDC codes (6)

Package NDCDescriptionSince
68382-255-01100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-01)Aug 10, 2017
68382-255-05500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-05)Aug 10, 2017
68382-255-0630 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-06)Aug 10, 2017
68382-255-1460 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-14)Aug 10, 2017
68382-255-1690 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-255-16)Aug 10, 2017
68382-255-7710 BLISTER PACK in 1 CARTON (68382-255-77) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (68382-255-30)Aug 10, 2017

Recalls mentioning this NDC

Other Oxybutynin products